Quantum computing for healthcare and life sciences, from research question to prototype.

Simulating molecules is the problem quantum computers were first imagined for, which makes life sciences one of the fields most likely to benefit early. We help research and data teams separate realistic near-term experiments from long-term bets, prototype them on properly governed data, and protect sensitive records against the quantum security risk.

Book a strategy call

What we cover

Why this fieldWhy life sciences is a leading candidate
Use casesWhere we help research and operations teams
Handling dataRegulated data, governed like any other project
How we workSmall experiments with clear questions

Why this field

Why life sciences is a leading candidate

Molecules follow the rules of quantum mechanics, and simulating them exactly on classical computers becomes impractical quickly as they grow. Quantum computers could, in principle, model molecular behavior more directly, which is why drug discovery, materials and chemistry feature in nearly every quantum roadmap.

The honest position today is that a useful advantage for real drug candidates still needs larger and more reliable machines than exist. What research teams can do now is build the skills, the data pipelines and the hybrid methods that will be ready when the hardware is, and test small problems that show whether a method is on the right track.

Use cases

Where we help research and operations teams

Molecular simulation is the long-term bet with the largest potential, and hybrid experiments on small molecules are how methods are developed and checked today. Quantum machine learning, such as using quantum circuits to extract features from signals or images before a classical model classifies them, is an active research area where results so far are mixed, so we always compare it with a well-tuned classical model.

Operational problems such as trial logistics, hospital capacity and staff scheduling can be tested today, and quantum-inspired methods are often the most practical there. Protecting data is not speculative at all: patient and research records that must stay confidential for decades are exactly what harvest-now, decrypt-later attacks target.

What we do

Hybrid quantum-classical experiments for molecular simulation and screening
Quantum machine learning experiments, compared with standard models
Optimization of trial logistics, hospital capacity and staff scheduling
Post-quantum protection for long-lived patient and research data

Handling data

Regulated data, governed like any other project

Healthcare and life sciences data carries obligations, whether it is patient information covered by HIPAA or research data under a sponsor's agreement. Quantum experiments do not change them. We work with de-identified or synthetic data where we can, keep data inside your environment or your approved cloud, and agree with you before anything runs exactly what may leave it for an external quantum service. Often that is only an abstract problem, such as a description of a molecule or an encoded optimization model, with no patient records in it.

Our SAS and data analytics teams already work with life sciences and other regulated data, and the same governance applies here: documented data flows, access limited to the people who need it, and results that can be explained and reproduced.

How we work

Small experiments with clear questions

Each engagement starts with a research or operational question and a conventional method to compare against. We scope an experiment small enough to run on simulators or on cloud quantum hardware, run it, and report what it showed, what it did not, and what would need to change for a larger test. Your scientists stay in charge of the science; we bring the quantum software, the data engineering and the computing environment.

What we do

A scoped research question and comparison method
Data preparation within your governance rules
Hybrid quantum-classical prototypes
A reproducible readout your team can extend

Questions

Common questions

Can quantum computing speed up drug discovery today?

Not for real drug candidates yet. Today's machines are too small and error-prone for molecules of practical size. Hybrid experiments on small molecules are useful for building methods and skills, and they are how research teams prepare for larger machines.

Will our patient data be sent to a quantum computer?

Only if you decide it should be, and usually it does not need to be. Most experiments use de-identified or synthetic data, and many quantum workloads need only an abstract description of the problem. We agree what may leave your environment before any work starts.

Do we need quantum specialists on our team?

Not to start. We bring the quantum software skills and work alongside your scientists and data team. If the work continues, we help your people build the skills to own it.

What does a first project look like?

Usually one question, one dataset and one comparison method, ending in a written readout and the code. From there you can decide whether a larger study is worth it.

Related services